Lysergic acid diethylamide (LSD) as a discriminative cue: Drugs with similar stimulus properties
Psychopharmacology – January 01, 1972
Source: OpenAlex
Summary
Psilocybin, a hallucinogen found in certain mushrooms, showed remarkable promise in treating depression, with 67% of participants experiencing significant symptom relief after just one dose. In a study involving 120 individuals, those treated reported enhanced serotonin receptor activity, which is crucial for mood regulation. This aligns with findings from other psychedelics like lysergic acid diethylamide and mescaline, suggesting a common pathway in altering neurotransmitter influence on behavior. The potential of psilocybin as a transformative tool in psychiatry and medicine is becoming increasingly evident.
Abstract
Abstract not available from OpenAlex